Absence of significant association between UGT2B4 genetic variants and the susceptibility to anti‐tuberculosis drug‐induced liver injury in a Western Chinese population.
What is known and objective: Combination regimens of six‐month duration may increase the incidence of anti‐tuberculosis drug‐induced liver injury (ATLI), which is clinically characterized by mild cholestasis and hepatocanalicular lesions. UGT2B4 is a predominant UDP‐glucuronosyltransferase enzyme in...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 46; no. 1; pp. 66 - 74 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |